Menu
Log in

HOME  /  JOIN  /  MAILING LIST  /  CONTACT US  /  WECHAT

Log in

GuidelinesGuidelines

Publications Publications

Initiative for Model Organisms Proteomics


Leadership and Team members

Chair:


Fabrice Bertile, Ph.D

CNRS/University Strasbourg, France


Co-Chairs:


Sabine Matallana-Surget, Ph.D

University of Stirling, UK




Susana Cristobal, Ph.D

Linköping University, Sweden




Andreas Tholey, Ph.D

Kiel University, Germany



Jean Armengaud, Ph.D

Paris-Saclay University, CEA, France


Early career researcher:



Tristan Cardon, Ph.D

Inserm, University of Lille, France




Unlocking New Model Organisms: Revolutionizing Health, Environment, and Biodiversity

Our overall aim is to promote the emergence of new model organisms. In particular, we consider organisms as models when they are suitable for i) the study of biological mechanisms important to human health and disease, ii) a better understanding of pathogenicity, pathogen reservoirs, and the emergence of resistance, and iii) deciphering the toxic effects of pollutants and exposomes on biological systems in order to define sentinels of our environment, or to be relevant to the One-Health concept. Furthermore, iMOP will allow for the characterization of non-referenced proteins across various models. 

Initiated in 2010, iMOP is at the forefront of Evolutionary Biology, Medicine, Environmental Proteomics, and Ecotoxicology. Through innovative approaches using comparative proteomics, proteogenomics, and (eco)toxicoproteomics, our initiative fosters collaborations between biologists and multi-omics specialists. By promoting multidisciplinary approaches, we tackle new challenging scientific questions and strive to enhance human health, environmental quality, and biodiversity conservation.

Researchers interested in our work are welcome to join us at every time. In particular we would like to motivate also early career researchers to join our team.  


Current line of work:

  • Promote the development of bioinformatics resources to improve comparisons between species and better link proteins from model organisms to human diseases (from possible new therapeutic targets to potentially new biologics)
  • Promote proteogenomics and multi-omics approaches, the improvement of genome annotations, and identification of the functions of proteoforms and non-canonical proteins
  • Promote proteomic studies in any model organism relevant to improving human health and environmental monitoring within the One-Health framework
  • Stimulate collaborations between biology and Omics communities
  • Promote iMOP visibility in publications and conferences.

Must read iMOP publications:


Tholey A, Taylor NL, Heazlewood JL, Bendixen E (2017). We are not alone: The iMOP initiative and its roles in a Biology and Disease driven Human Proteome Project. J Proteome Res, 16: 4273-4280.


Heazlewood JL, Schrimpf SP, Becher D, Riedel K, Tholey A, Bendixen E (2015). Multi-organism proteomes (iMOP): advancing our understanding of human biology. Proteomics, 15: 2885-2894. 


Initiative membership:

If you would like to become a member of HUPO-iMOP, please contact the chair or one of the co-chairs.

Announcements & upcoming events


iMOP Workshop @ HUPO2024

More to come...

 






The Human Proteome Organization is a 501(c)(3) tax exempt non-profit organization registered in the state of New Mexico.  |  ¬© 2001-2022 HUPO. All rights reserved. 

Powered by Wild Apricot Membership Software